VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Cohort 1: Recurrent or refractory medulloblastoma  │ Cohort 1: Recurrent or refractory medulloblastoma  │     100 │
│ in which current standard treatment approaches     │ in which current standard treatment approaches     │         │
│ have failed; biopsy is not required for recurrent  │ have failed; biopsy is not required for recurrent  │         │
│ disease                                            │ disease                                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Life expectancy ≥ 3 months                         │ Life expectancy ≥ 3 months                         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Diagnosis of brainstem glioma                      │ Diagnosis of brainstem glioma                      │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Concurrent administration of any other anti-tumor  │ Concurrent administration of any other anti-tumor  │     100 │
│ therapy                                            │ therapy                                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pre-existing uncontrolled diarrhea                 │ Pre-existing uncontrolled diarrhea                 │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Cohort 2: Newly-diagnosed high-grade glioma (World │ Cohort 2: Newly-diagnosed high-grade glioma (World │      99 │
│ Health Organization \[WHO\] grade 3 or 4)          │ Health Organization [WHO] grade 3 or 4)            │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                     │   Score │
╞═══════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Must have maximum age of 18 Years │ Concurrent administration of any other anti-tumor │      33 │
│                                   │ therapy                                           │         │
├───────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 6 Months │ Concurrent administration of any other anti-tumor │      40 │
│                                   │ therapy                                           │         │
╘═══════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 92
Average Levenshtein Ratio of individual lines: 84.0
OverAll Ratio: 88.0
